hydase
Pharmaranks rates Hydase 2.9/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Hydase (Hyaluronidase) is a medication used to treat Extravasation of Diagnostic and Therapeutic Materials.
Hyaluronidase · by Akorn Inc
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Hyaluronidase
- Form
- Injectable
- Strength
- Hyaluronidase 150 UNITS/ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Akorn Inc
- FDA application
- BLA021716
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Hydase treat?
- Hydase (Hyaluronidase) may be used to treat extravasation of diagnostic and therapeutic materials, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Hydase rated?
- pharmaranks gives Hydase a composite score of 2.9 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Hydase?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Hydase. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Hydase?
- Hydase is marketed by Akorn Inc. You can see Akorn Inc's full profile, rating, and other products on pharmaranks.
- Is Hydase a brand-name or generic drug?
- Hydase is a brand-name product with the active ingredient Hyaluronidase.
- Is Hydase available over the counter?
- No. Hydase is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Hydase come in?
- Hydase is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Hydase FDA-registered?
- Hydase is on record with the U.S. FDA under application number BLA021716. You can verify this on its official FDA label.
- Has Hydase been recalled by the FDA?
- Hydase has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Hydase safe?
- There's no single safe-or-not verdict. pharmaranks gives Hydase a recall-safety score of 58/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about HYALURONIDASE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 7,548 reports naming HYALURONIDASE — the active ingredient in Hydase, and the FDA flagged 91% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- fatigue1,182 reports
- pneumonia1,107 reports
- headache1,030 reports
- sinusitis1,014 reports
- pyrexia937 reports
- malaise871 reports
- inappropriate schedule of product administration801 reports
- infection760 reports
Read these as a signal, not a rate. A report does not mean HYALURONIDASE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Hydase head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
hydase
58/100